Martin Vazquez - Mar 1, 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chief Operating Officer
Signature
By: John L Brottem For: Martin Vazquez
Stock symbol
OM
Transactions as of
Mar 1, 2022
Transactions value $
-$174,459
Form type
4
Date filed
3/2/2022, 03:47 PM
Previous filing
Feb 3, 2022
Next filing
Mar 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $43.1K +5K +9.9% $8.62 55.5K Mar 1, 2022 Direct
transaction OM Common Stock Sale -$218K -5K -9% $43.51 50.5K Mar 1, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -5K -7.45% $0.00 62.2K Mar 1, 2022 Common Stock 5K $8.62 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 745 shares; $43.00-$43.99 - 3,355 shares; $44.00 - $44.99 - 900 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option vests in 48 equal monthly installments beginning on March 3, 2020, subject to the reporting person's continued employment through the applicable vesting date.